Decoding complexity. Advancing precision medicine.
Building next-generation platforms for translational oncology and precision immunotherapy.
Building next-generation platforms for translational oncology and precision immunotherapy.
We develop computational pipelines capable of transforming raw sequencing data into prioritised therapeutic opportunities — enabling faster and more precise translational research.
By combining tumour DNA, normal DNA and RNA expression profiles, Ilys reveals hidden biological signals that conventional analysis often fails to detect.
Our technologies are designed to support the next generation of personalised cancer therapies through actionable neoantigen identification and advanced molecular interpretation.
We collaborate with researchers, clinical teams and innovation partners exploring next-generation translational oncology and personalised immunotherapy.